Paper29607136
Anti-inflammatory therapy with canakinumab for atherosclerotic disease: lessons from the CANTOS trial.
Thompson PL and 1 other. J Thorac Dis, 2018. Cited by 46 papers, by iCite.
Cite this record
ConductScience Library. Anti-inflammatory therapy with canakinumab for atherosclerotic disease: lessons from the CANTOS trial. Papers, record 29607136. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29607136
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Anti-inflammatory therapy with canakinumab for atherosclerotic disease: lessons from the CANTOS trial.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment on | 28845751 | Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease. | https://conductscience.org/library/papers/28845751 |
Source PubMed
References20
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21471964 | Cardiovascular and gastrointestinal safety of NSAIDs: a systematic review of meta-analyses of randomized clinical trials. | Clin Pharmacol Ther | 2011 | https://conductscience.org/library/papers/21471964 | PubMed |
| 2 | 25917947 | Novel anti-inflammatory therapies for the treatment of atherosclerosis. | Atherosclerosis | 2015 | https://conductscience.org/library/papers/25917947 | PubMed |
| 3 | 24916606 | Methotrexate for treating rheumatoid arthritis. | Cochrane Database Syst Rev | 2014 | https://conductscience.org/library/papers/24916606 | PubMed |
| 4 | 24864079 | Anti-inflammatory therapies for cardiovascular disease. | Eur Heart J | 2014 | https://conductscience.org/library/papers/24864079 | PubMed |
| 5 | 26816301 | Colchicine for prevention of cardiovascular events. | Cochrane Database Syst Rev | 2016 | https://conductscience.org/library/papers/26816301 | PubMed |
| 6 | 23895801 | Rationale and design of the Cardiovascular Inflammation Reduction Trial: a test of the inflammatory hypothesis of atherothrombosis. | Am Heart J | 2013 | https://conductscience.org/library/papers/23895801 | PubMed |
| 7 | 28845751 | Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease. | N Engl J Med | 2017 | https://conductscience.org/library/papers/28845751 | PubMed |
| 8 | 28855077 | Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial. | Lancet | 2017 | https://conductscience.org/library/papers/28855077 | PubMed |
| 9 | 23265346 | Low-dose colchicine for secondary prevention of cardiovascular disease. | J Am Coll Cardiol | 2013 | https://conductscience.org/library/papers/23265346 | PubMed |
| 10 | 21855836 | Systematic review and meta-analysis of methotrexate use and risk of cardiovascular disease. | Am J Cardiol | 2011 | https://conductscience.org/library/papers/21855836 | PubMed |
| 11 | 29146124 | Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial. | Lancet | 2018 | https://conductscience.org/library/papers/29146124 | PubMed |
| 12 | 28844177 | Targeting Inflammation in Coronary Artery Disease. | N Engl J Med | 2017 | https://conductscience.org/library/papers/28844177 | PubMed |
| 13 | 29055633 | Colchicine Therapy and Plaque Stabilization in Patients With Acute Coronary Syndrome: A CT Coronary Angiography Study. | JACC Cardiovasc Imaging | 2018 | https://conductscience.org/library/papers/29055633 | PubMed |
| 14 | 28298374 | Safety of synthetic and biological DMARDs: a systematic literature review informing the 2016 update of the EULAR recommendations for management of rheumatoid arthritis. | Ann Rheum Dis | 2017 | https://conductscience.org/library/papers/28298374 | PubMed |
| 15 | 9887164 | Atherosclerosis--an inflammatory disease. | N Engl J Med | 1999 | https://conductscience.org/library/papers/9887164 | PubMed |
| 16 | 22850787 | Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases. | Nat Rev Drug Discov | 2012 | https://conductscience.org/library/papers/22850787 | PubMed |
| 17 | 17350370 | Effect of colchicine (0.5 mg twice daily) on high-sensitivity C-reactive protein independent of aspirin and atorvastatin in patients with stable coronary artery disease. | Am J Cardiol | 2007 | https://conductscience.org/library/papers/17350370 | PubMed |
| 18 | 25079365 | The effect of interleukin-1 receptor antagonist therapy on markers of inflammation in non-ST elevation acute coronary syndromes: the MRC-ILA Heart Study. | Eur Heart J | 2015 | https://conductscience.org/library/papers/25079365 | PubMed |
| 19 | 24678955 | Darapladib for preventing ischemic events in stable coronary heart disease. | N Engl J Med | 2014 | https://conductscience.org/library/papers/24678955 | PubMed |
| 20 | 20668705 | Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation. | PLoS One | 2010 | https://conductscience.org/library/papers/20668705 | PubMed |
Cited by38
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 46 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42941917 | Immune Dysregulation as a Driver of Coronary Heart Disease. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42941917 | PubMed |
| 42819046 | Inflammatory drivers of carotid atherosclerosis: signaling pathways, immune cells, and plaque stability. | Front Cardiovasc Med | 2026 | https://conductscience.org/library/papers/42819046 | PubMed |
| 42783044 | Arrhythmic Mitral Valve Prolapse as a Regional Stretch-Induced Cardiomyopathy with Fibro-Inflammatory Signature: A Conceptual Review. | J Cardiovasc Dev Dis | 2026 | https://conductscience.org/library/papers/42783044 | PubMed |
| 42279002 | Anti-Inflammatory Therapies in Acute Coronary Syndromes-A Review of Immunological, Genetic, and Clinical Challenges for Precision Medicine. | J Clin Med | 2026 | https://conductscience.org/library/papers/42279002 | PubMed |
| 41732594 | Metabolic Inflammation as a Common Thread in Cardio-Endocrine Diseases: Toward a Unified Therapeutic Framework. | Cureus | 2026 | https://conductscience.org/library/papers/41732594 | PubMed |
| 41595651 | Glial Cell Dynamics in Neuroinflammation: Mechanisms, Interactions, and Therapeutic Implications. | Biomedicines | 2026 | https://conductscience.org/library/papers/41595651 | PubMed |
| 41511355 | Inflammatory Mechanisms in Acute Coronary Syndromes: From Pathophysiology to Therapeutic Targets. | Cells | 2025 | https://conductscience.org/library/papers/41511355 | PubMed |
| 41305751 | Bibliometric analysis of atrial fibrillation and frailty research based on CiteSpace and VOSviewer. | Medicine (Baltimore) | 2025 | https://conductscience.org/library/papers/41305751 | PubMed |
| 41158407 | Thromboelastography and interleukin-6 predict postoperative negative remodeling of descending aorta in patients with type A aortic dissection. | J Thorac Dis | 2025 | https://conductscience.org/library/papers/41158407 | PubMed |
| 40699816 | Neuroinflammation: Mechanisms, Dual Roles, and Therapeutic Strategies in Neurological Disorders. | Curr Issues Mol Biol | 2025 | https://conductscience.org/library/papers/40699816 | PubMed |
| 40530726 | Targeting Inflammation in Type 2 Diabetes: The Role of Colchicine. | Curr Diabetes Rev | 2026 | https://conductscience.org/library/papers/40530726 | PubMed |
| 40488107 | Mechanotransduction for therapeutic approaches: Cellular aging and rejuvenation. | APL Bioeng | 2025 | https://conductscience.org/library/papers/40488107 | PubMed |
| 40433411 | Inflammasomes: novel therapeutic targets for metabolic syndrome? | Front Endocrinol (Lausanne) | 2025 | https://conductscience.org/library/papers/40433411 | PubMed |
| 40384967 | Foamy macrophages in atherosclerosis: unraveling the balance between pro- and anti-inflammatory roles in disease progression. | Front Cardiovasc Med | 2025 | https://conductscience.org/library/papers/40384967 | PubMed |
| 40153759 | Predictive value of cumulative SII for MACE in STEMI patients after PCI. | Medicine (Baltimore) | 2025 | https://conductscience.org/library/papers/40153759 | PubMed |
| 40104140 | Systemic inflammation prevalence in patients with atherosclerotic cardiovascular disease and chronic kidney disease: a population-based study using a nationwide primary care database in Spain. | Front Cardiovasc Med | 2025 | https://conductscience.org/library/papers/40104140 | PubMed |
| 39958615 | Association of systemic inflammatory response index and stroke: a cross-sectional study of NHANES, 2005-2018. | Front Neurol | 2025 | https://conductscience.org/library/papers/39958615 | PubMed |
| 39936945 | Inflammatory Pathways in Coronary Artery Disease: Which Ones to Target for Secondary Prevention? | Cells | 2025 | https://conductscience.org/library/papers/39936945 | PubMed |
| 39465131 | Human and gut microbiota synergy in a metabolically active superorganism: a cardiovascular perspective. | Front Cardiovasc Med | 2024 | https://conductscience.org/library/papers/39465131 | PubMed |
| 39204382 | Emerging Trends and Innovations in the Treatment and Diagnosis of Atherosclerosis and Cardiovascular Disease: A Comprehensive Review towards Healthier Aging. | Pharmaceutics | 2024 | https://conductscience.org/library/papers/39204382 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29607136
GET https://conductscience.org/api/papers/v1/29607136/cited_by?page=2